17th Apr 2007 16:12
Oxford Biomedica PLC17 April 2007 Oxford BioMedica plc ("Oxford BioMedica" or the "Company") Annual Information Update for the Twelve Months to 2 April 2007 This annual information update is filed pursuant to Prospectus Rule 5.2 made bythe Financial Services Authority and not for any other purpose and by filingthis annual information update neither the Company, nor any other person, takesany responsibility for, or makes any representation, express or implied, as tothe accuracy or completeness of, the information contained or referred to belowherein. The information referred to below is not necessarily up to date as atthe date of this annual information update and the Company does not undertakeany obligation to update any such information in the future. Furthermore, suchinformation may have been prepared in accordance with the laws or regulations ofa particular jurisdiction and may not comply with or meet the relevant standardsof disclosure in any other jurisdiction. Neither this annual information update,nor the information referred to below constitutes, by virtue of thiscommunication, an offer of any securities addressed to any person and should notbe relied on by any person. 1. Announcements made via a Regulatory Information Service Date Announcement 30 March 2007 Total voting rights update29 March 2007 Notice of AGM28 March 2007 Agreement to develop TroVax20 March 2007 Holding(s) in Company16 March 2007 Holding(s) in Company16 March 2007 Holding(s) in Company15 March 2007 Re acquisition of Oxxon Therapeutics Limited12 March 2007 Acquisition of Oxxon Therapeutics Limited6 March 2007 Preliminary results for 200628 February 2007 Total voting rights update27 February 2007 Holding(s) in Company27 February 2007 Notice of results22 February 2007 Holding(s) in Company20 February 2007 Holding(s) in Company14 February 2007 Holding(s) in Company9 February 2007 Holding(s) in Company7 February 2007 Holding(s) in Company1 February 2007 Result of EGM31 January 2007 Total voting rights update24 January 2007 Holding(s) in Company24 January 2007 Avian Transgenic project milestone16 January 2007 Publication results from avian transgenic programme10 January 2007 Phase III trial in TroVax adopted in UK by NCRN4 January 2007 Total voting rights update2 January 2007 Total voting rights amendment22 December 2006 Total voting rights statement21 December 2007 LentiVector licence signed with GlaxoSmithKline19 December 2006 Holding(s) in Company19 December 2006 Lentivector licence with major drug company expanded8 December 2006 Holding(s) in Company8 December 2006 TroVax positive EU orphan drug recommendation5 December 2006 Holding(s) in Company21 November 2006 Blocklisting interim review13 November 2006 ProSavin preclinical data presented9 November 2006 TroVax phase II data presented7 November 2006 TroVax commencement of phase III trial6 October 2006 TroVax phase II data presented2 October 2006 Expansion of ocular disease programme and shares subscription25 September 2006 Holding(s) in Company20 September 2006 Holding(s) in Company7 September 2006 Directors' interests in share options5 September 2006 Interim results5 September 2006 TroVax phase II trial update re SWOG breast cancer trial21 August 2006 TroVax phase II data presented3 August 2006 Holding(s) in Company31 July 2006 Update and clarification on TroVax18 July 2006 Holding(s) in Company6 July 2006 Holding(s) in Company5 July 2006 Director/PDMR shareholding29 June 2005 Holding(s) in Company26 June 2006 Holding(s) in Company26 June 2006 ProSavin patent notice of allowance21 June 2006 Oxford BioMedica to present at Piper Jaffray healthcare conference14 June 2006 Oxford BioMedica and Sigma-Aldrich suit against Open Biosystems12 June 2006 Holding(s) in Company7 June 2006 TroVax phase II results presented23 May 2006 TroVax phase II trial in prostate cancer starts22 Mat 2006 Holding(s) in Company18 May 2006 Blocklisting interim review16 May 2006 Director/PDMR shareholding12 May 2006 TroVax receives Special Protocol Assessment for phase III trial in renal cancer4 May 2006 AGM statement2 May 2006 RetinoStat preclinical data presented20 April 2006 Holding(s) in Company11 April 2006 Annual report 2005 lodged with FSA11 April 2006 Annual information update Details of all regulatory announcements for Oxford BioMedica can be found on theLondon Stock Exchange website at www.londonstockexchange.com and on the OxfordBioMedica website at http://www.oxfordbiomedica.co.uk 2. Documents filed with Companies House Date Document Type Description 28 February 2007 88(2) Return of Allotment of shares Allotment 313,017 1p Ord.28 February 2007 88(2) Return of Allotment of shares Allotment 82,007 1p Ord.10 January 2007 288a Appointment of director Dr Michael McDonald15 December 2006 88(2) Return of Allotment of shares Allotment 111,864 1p Ord.13 December 2006 88(2) Return of Allotment of shares Allotment 266,124 1p Ord.17 November 2006 88(2) Return of Allotment of shares Allotment 173,140 1p Ord.17 November 2006 88(2) Return of Allotment of shares Allotment 485,185 1p Ord.17 November 2006 88(2) Return of Allotment of shares Allotment 357,583 1p Ord.17 November 2006 88(2) Return of Allotment of shares Allotment 348,435 1p Ord.17 November 2006 88(2) Return of Allotment of shares Allotment 25,490 1p Ord.17 November 2006 88(2) Return of Allotment of shares Allotment 1,023,870 1p Ord.17 November 2006 88(2) Return of Allotment of shares Allotment 64,864 1p Ord.17 November 2006 88(2) Return of Allotment of shares Allotment 49,895 1p Ord. 20 October 2006 363s Annual Return Copies of documents filed at Companies House can be obtained from CompaniesHouse, Crown Way, Cardiff CF14 3UZ or through Companies House Direct atwww.direct.companieshouse.gov.uk 3. Documents published or sent to shareholders or filed with the UKLA ViewingFacility Date Description2 April 2007 Annual Report - year ended 31 December 2006 and Notice of Annual General Meeting10 January 2007 Notice of Extraordinary General Meeting5 September 2006 Interim Report for 6 months to 30 June 20066 April 2006 Annual Report - year ended 31 December 2005 and Notice of Annual General Meeting Copies of all the above documents may be obtained from the Company Secretary atthe Company's Registered Office: Oxford BioMedica plcMedawar CentreRobert Robinson AvenueThe Oxford Science ParkOxfordOX4 4GA 17 April 2007 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Oxford Biomedica